Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01688856 · ClinicalTrials.gov registry record · NA

Contralaterally Controlled FES of Arm & Hand for Subacute Stroke Rehabilitation

A NA study, sponsored by MetroHealth Medical Center.

Completed
Registry status
NA
Development phase
67
Enrollment target

NCT01688856 is a NA study that has completed, run by MetroHealth Medical Center. The registered enrollment target is 67 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01688856, a NA study, has completed, sponsored by MetroHealth Medical Center.

COMPLETED
Registry status
NA
Development phase
67 participants
Enrollment target

Study Summary

Impaired arm and hand function is one of the most disabling and most common consequences of stroke. The Investigators have developed Contralaterally Controlled Functional Electrical Stimulation (CCFES), an innovative neuromuscular electrical stimulation (NMES) treatment for improving the recovery of hand function after stroke. The purpose of this study is to maximize the treatment effect of CCFES by adding stimulated elbow extension. The specific aims and hypotheses are as follows: AIM 1: Estimate the effect of Arm+Hand CCFES on upper limb motor impairment and activity limitation. Hypothesis 1: Stroke survivors treated with Arm+Hand CCFES have better outcomes on upper limb impairment and activity limitation measures than those treated with dose-matched Arm+Hand Cyclic NMES. AIM 2: Estimate the effect of adding stimulated elbow extension to Hand CCFES. Hypothesis 2: Stroke survivors treated with Arm+Hand CCFES will have greater reductions in upper limb impairment and activity limitation than those treated with Hand CCFES. AIM 3: Describe the relationship between treatment effect and time elapsed between stroke onset and start of treatment. Hypothesis 3: Patients who start Arm+Hand CCFES sooner after their stroke achieve better outcomes.

Interventions

  • DEVICE Electrical Stimulator

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2013-01
Est. Completion 2018-08-31
Phase NA

Sponsor

MetroHealth Medical Center

76 total trials

What the Registry Record Tells You About NCT01688856

The ClinicalTrials.gov registry entry for NCT01688856 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MetroHealth Medical Center, which has 76 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Electrical Stimulator is the first listed.

NCT01688856 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01688856 about?

NCT01688856 is a clinical study titled "Contralaterally Controlled FES of Arm & Hand for Subacute Stroke Rehabilitation". Impaired arm and hand function is one of the most disabling and most common consequences of stroke. The Investigators have developed Contralaterally Controlled Functional Electrical Stimulation (CCFES), an innovative neuromuscular electrical stimulation (NMES) treatment for improving the recovery of...

What is the current status of trial NCT01688856?

This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2013-01. Estimated completion is 2018-08-31.

What interventions are being tested in trial NCT01688856?

The interventions under investigation include: Electrical Stimulator (DEVICE).

Who is sponsoring clinical trial NCT01688856?

This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.